Babies who are large for gestational age may have: q increased risk of birth trauma q risk of hypoglycaemia, increased feeding required q polycythaemia.
The most common cause of babies being large for gestational age is maternal diabetes. Other causes include babies with transposition of the great vessels, those with Beckwith-Wiedemann syndrome and those born post-term.
Premedication
Neonates do not usually require sedation. Atropine, can be given when required, either orally or, less frequently, IM. It is used for vagolytic activity and to decrease airway secretions. Atropine may also be given IV on induction, either routinely, or if bradycardia occurs.
Ametop can be used as a local anaesthetic cream to assist IV cannulation. EMLA is not recommended for babies < 12 months old as metabolism of prilocaine may produce methaemoglobinaemia.
Investigations

Haemoglobin
All neonates should have a haemoglobin estimation before surgery as the concentration is related to the degree of foetal/maternal transfusion at birth and is therefore unpredictable. Babies who have been in hospital for prolonged periods are frequently anaemic because of: q disease q difficulties with establishing adequate feeding q repeated blood sampling.
Anaemia is associated with an increased incidence of apnoea postoperatively, particularly in the premature neonate. Sickle cell disease testing At birth, the main form of haemoglobin is fetal haemoglobin (HbF). This is gradually replaced, in the first 3 months of life, by adult forms of haemoglobin, usually haemoglobin A (HbA).
In patients with sickle cell disease (SCD) HbF is replaced by haemoglobin S rather than HbA so that by about 3 months significant amounts of HbS are present.
Initially, babies with SCD are protected from the effects of abnormal haemoglobin by the high HbF concentration. This means that Sickledex screening may provide false negatives in a very young baby with sickle cell disease, as HbS levels are so low. However, electrophoresis will be accurate in this age group as it identifies all haemoglobin types present. Many babies at risk from SCD can be screened using cord blood and this is routinely done in many centres.
Bilirubin
Neonates are frequently jaundiced; 80% of preterm babies and 50% of term babies have jaundice. There are many causes, but jaundice until 4 weeks of age can be physiological. Jaundice may be due in part to relative polycythaemia at birth and the immature hepatic enzymes that are unable to deal with the additional red cell load. Physiological jaundice is due to increased unconjugated bilirubin values. If conjugated bilirubin is raised, then other causes must be sought. Physiological jaundice may be treated with phototherapy or exchange transfusion, as unconjugated bilirubin can cross the immature blood-brain barrier and cause brain damage (kernicterus).
Other investigations are dictated by the baby's physical condition. Clotting studies are often required, as neonates are at risk from coagulation factor deficiencies due to: q immaturity of the coagulation system q presence of sepsis, frequently associated with thrombocytopenia and coagulopathy q jaundice q vitamin K deficiency.
Vitamin K Vitamin K is necessary for production of hepatic coagulation factors II, IV, IX and X. It is given routinely at birth to prevent haemorrhagic disease of the newborn. Vitamin K is given either IM as a single injection or as a course of three oral doses. The anaesthetist should ensure that Vitamin K has been given before surgery.
Induction and maintenance of anaesthesia
Sevoflurane is the inhalational induction agent of choice in most neonates. It has a rapid onset with cardiovascular stability. Thiopentone remains a useful agent, but propofol is unlicenced in this age group and there is little information about this agent in neonates. Ketamine is used occasionally.
For all but the shortest procedures, neonates require tracheal intubation and ventilation. This is because the functional residual capacity is reduced so that closing volumes are near to tidal volumes leading to the risk of ventilation/perfusion mismatch.
It is necessary to minimize apparatus dead space. Whilst the size 1 LMA TM provides a convenient airway it is liable to dislodgement and longer procedures are poorly tolerated due to the small degree of respiratory reserve in neonates.
Atracurium is the most useful muscle relaxant as neonatal enzyme systems are immature with unpredictable metabolism of other relaxant drugs.
Maintenance of anaesthesia is with oxygen in either nitrous oxide or air. It is important to avoid administration of excessive concentrations of oxygen in premature babies.
A nasogastric tube is used as abdominal distension inhibits lung expansion and ventilation may be compromised.
Management of temperature
Small babies loose heat quickly and have poorly developed physiological mechanisms for maintaining body heat.
Measures used to aid thermal care
q Always monitor temperature. q Maintain a warm thermal environment, increase theatre temperature. q Use active warming, e.g. an overhead radiant heater. q Transfer in an incubator. q Warm inspired gases or use a heat-moisture exchanger. q Heat conservation-wrap exposed areas using foil, bubble plastic or cotton gamgee. q Use warm air mattress. q Warm IV fluids.
Analgesia
Historically, neonates were thought not to feel pain but this has been disproved. Babies mount a significant hormonal stress response to surgery if they are not given sufficient anaesthesia or analgesia. It has been suggested that they have increased morbidity and mortality if anaesthesia is inadequate. It is often difficult to assess pain in the very young as their responses are different from older children.
Pain management during minor surgery is often provided by the combination of local anaesthesia (either as a block or as infiltration of the wound) and paracetamol. Following major surgery, pain management with epidurals or morphine infusions can be used in neonates providing the child can be monitored adequately in a high-dependency area.
Local anaesthetic Blocks such as caudal or ilioinguinal are used commonly. It is often useful for the surgeon to inject the local anaesthetic by the ilioinguinal nerve under direct vision. Epidural (caudal or lumber) and spinal blocks have been used in neonates for many years.
The maximum safe dose of local anaesthetics is lower in neonates. Plain bupivacaine or ropivacaine are used for epidual analgesic. Opiates are avoided as they have an increased incidence of side effects, particularly respiratory depression.
Paracetamol
Paracetamol is used to a maximum dose of 60 mg/kg/day, orally or rectally.
Non-steroidal anti-inflammatory drugs (NSAIDs)
NSAIDs are not used for analgesia in this age group as the renal system is immature and their effect has not been extensively investigated.
Opiates
Codeine phosphate 1 mg/kg IM or rectally is useful after minor/moderate surgery and is safe provided it is not given IV. Particular care must be taken with the use of opiates in neonates. Morphine, fentanyl, alfentanil and remifentanil are all used. The incidence of complications, such as apnoea or respiratory depression is increased, particularly in babies < 5 kg. High-dependency care is required postoperatively if opiate infusions are used.
Fluid management
Fluid requirements can be divided into:
q Maintenance fluids, to cover the preoperative, perioperative and postoperative period.
q Third space and evaporative losses. q Replacement of blood and clotting factors.
The fluid status of a baby is assessed using the following indicators:
q skin turgor q peripheral perfusion, capillary refill time, e.g. of the finger tips q fullness or sunken quality of the anterior fontanelle q alterations in pulse and blood pressure q haemoglobin and urea and electrolyte values q estimation of insensible losses, for example, if the intestine is exposed the additional losses are approximately 5 ml/kg/h q urine output (but this may be negligible on day one in the normal baby) q knowledge of hourly requirements q additional losses, e.g. blood, nasogastic fluid.
Routine maintenance fluid requirements in the newborn
q day 1 of life-2 ml/kg/h q day 2-3 ml/kg/h q day 3-4 ml/kg/h. Maintenance fluid requirements on the first postoperative day are decreased to 2/3 of the usual daily amount.
Choice of fluid q crystalloid -used for maintenance q colloid -gelatin, albumin q blood products.
Crystalloid
The choice of maintenance crystalloid fluid depends on the glucose and electrolyte needs. Usually 4% or 10% dextrose in 0.18% saline is used, with increased concentrations of dextrose if hypoglycaemia is likely. When losses from the gut are present, these are replaced with 0.9% saline with 10 mmol of potassium added to each 500 ml of fluid. This mixture is used to replace the hourly nasogastric volume on a millilitre for millilitre basis. These are guidelines only and fluid management requires careful monitoring of glucose and electrolyte values. The renal function of babies matures over the first few months. Neonates are not able to excrete large volumes of water and may develop oedema easily. If an additional bolus of crystalloid is required it is usually given as IV saline or Hartmann's solution. Care must be taken not to administer excess crytalloid. Hypnotic solutions should not be used for volume replacement.
Hypoglycaemia
Neonates, and particularly premature or small for gestational age babies, are at risk perioperatively of hypoglycaemia, Although babies do have a glycaemic response to surgery due to surgical stress, they remain at risk of developing hypoglycaemia. It is important that small babies are provided with additional glucose, either by oral fluids or by infusion, if they are starved for long periods preoperatively. They may need additional 10% glucose infusion perioperatively. Term neonates can usually tolerate fasting according to standard guidelines. However, it is wise to measure blood glucose following induction of anaesthesia and treat hypoglycaemia if present with a bolus dose of 1-2 ml/kg of 10-15% dextrose.
Colloid
The use of albumin has become controversial after adult work linking its use with increased mortality in the intensive care unit. The relevance of this to neonates is unclear.
Other colloids such as the starch or gelatin solutions have not been extensively studied in neonates, but are used. There is concern that there may be accumulation of starch in the reticuloendothelial system of the neonate.
Blood
Perioperative blood losses must be closely monitored. Frequent determinations of haemoglobin allow accurate blood replacement. The aim is to achieve a normal neonatal Hb level by the end of surgery (see Box 6.1 above).
Blood volume needed = Hct1 − Hct2 × EBV Hct3 Hct1 = haematocrit before transfusion, the measured haematocrit. Hct2 = haematocrit required after transfusion, the desired haematocrit. Hct3 = haematocrit of the blood to be given (60% if packed cells). EBV = estimated blood volume.
Sepsis in the neonate is frequently associated with thrombocytopenia and coagulopathy. Blood products such as fresh frozen plasma (FFP) and platelets may be required occasionally, especially in sick neonates undergoing major abdominal surgery. The use of these products should be guided by the results of a coagulation screen and full blood count.
Use of blood products in neonates q Small babies tolerate blood loss poorly. q It is usual to cross match blood for many procedures which would not require transfusion in older patients, such as formation of colostomy or insertion of Hickman line. q Cross-matching blood has specific additional requirements in this age group: q Blood of the most recent donation should be used if large transfusion is required. Fresh whole blood contains clotting factors and active platelets so is very useful in sick neonates. q Blood must be filtered to remove white blood cells, which may transmit prion disease. q Babies with a presumptive diagnosis of DiGeorge syndrome require irradiated blood products. q Cytomegalovirus (CMV)-negative blood is used in neonates as their immune system is immature and CMV infection can be fatal. q FFP is used to replace clotting factors, (initially 10 ml/kg). This does not need cross-matching but is type specific; it must be given through a 150 µm filter. q Platelets are given only if the platelet count is low. Ideally, a single donor unit is used.
Fasting guidelines in neonates
q Breast milk may be given until 4 h preoperatively. q Dextrose solutions may be given until 2 h preoperatively. q Formula milk feeds may be given until 6 h preoperatively. These milks contain cow protein and are more slowly digested than breast milk. q Babies having continuous feed via jejunal catheters should have these stopped 4 h preoperatively.
If surgery is delayed for extended periods, IV fluids must be given, or if time permits, additional clear oral fluids are given.
Monitoring
Routine monitoring should be used and is specifically designed for babies. This includes electrocardiogram, non-invasive blood pressure, FiO 2 , E t CO 2 , anaesthetic agent, temperature, and neuromuscular function. As many neonates will have a patent ductus arteriosus the pulse oximeter should be placed on the right hand, if possible, to measure preductal SpO 2 : q E t CO 2 monitoring is useful but the alveolar-arterial gradient may be considerable so that arterial CO 2 is poorly represented by E t CO 2 . q In major cases, an arterial cannula is useful, usually in the radial, femoral or axillary artery. q Central venous pressure is measured via the femoral or internal jugular vein.
Immediate postoperative management
At the end of surgery, most babies are extubated when awake and go to the recovery room. Neonates are not usually managed as day cases. Premature and expremature neonates will require additional monitoring for apnoea and bradycardia for at least the first 24 h postoperatively. Term neonates do not require this monitoring routinely. High-risk neonates, or those having extensive surgery, go to the neonatal unit and some will be electively ventilated postoperatively.
The premature and expremature baby Babies born at less than 37 completed weeks of gestation are defined as preterm.
Conditions associated with prematurity include q respiratory distress syndrome q chronic lung disease q bronchopulmonary dysplasia q intraventricular haemorrhage q visual or hearing loss q retinopathy of prematurity q increased incidence of congenital abnormalities q necrotizing enterocolitis q acquired subglottic stenosis q persistent patent ductus arteriosus q failure to thrive q developmental delay q cerebral palsy.
Retinopathy of prematurity
High PaO 2 in premature babies is associated with retrolental hyperplasia of the blood vessels, which may lead to retinopathy of prematurity and blindness. The aim is to keep the SPO 2 between 90% and 96%. The risk persists until about 8 months of age, and decreases with time, and the risk to an individual baby is difficult to estimate.
Postoperative apnoea
Apnoea is very common in preterm babies, and often associated with bradycardia. The risk is increased in premature babies following general anaesthesia or the use of sedation. Premature babies may have a history of apnoea which can be central, obstructive or mixed in aetiology.
Various definitions are used for postoperative apnoea, but a cessation of respiration for 15-20 sec, which may be associated with desaturation and bradycardia, is commonly used. These episodes are usually selflimiting or require mild stimulation of the baby to encourage respiration. Apnoea is more common in the more premature babies and occurs mainly in the first 24 h postoperatively.
Risk factors are:
q age less than 56-60 weeks PGA q neurological disease q anaemia q general anaesthesia q sedation q opiate use q known respiratory disease, e.g. bronchopulmonary dysplasia q preoperative oxygen requirement.
Management
q Optimize condition preoperatively, e.g. treat anaemia. q Monitor with a pulse oximeter and apnoea monitor for at least 24 h postoperatively. q Consider use of caffeine pre-and postoperatively to decrease the risk of apnoea. q Postpone routine surgery until after 60 weeks' PGA. q Do not treat expremature babies as day cases until after 60 weeks'
PGA.
